Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.
about
The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndromeThe Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in AtherosclerosisSimvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectCirculating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetesDifferences in musculoskeletal health due to gender in a rural multiethnic cohort: a Project FRONTIER study.LDL biochemical modifications: a link between atherosclerosis and aging.Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits.Serum Oxidized LDL Levels in Type 2 Diabetic Patients with Retinopathy in Mthatha Region of the Eastern Cape Province of South Africa.Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma.Association of the SPTLC3 rs364585 polymorphism and serum lipid profiles in two Chinese ethnic groups.The SRGAP2 SNPs, their haplotypes and G × E interactions on serum lipid traits.Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitisClinical relevance of gemstone spectral CT in the diagnosis of carotid atherosclerosisCalcifying Matrix Vesicles and Atherosclerosis.New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.
P2860
Q26740361-61866770-B2D1-4934-AF29-4426EE112EE8Q26769783-248C8222-58D1-4A5A-B5A5-CB3EC04A86FAQ28553042-2281B47A-C6C6-42DE-BF23-CC9BD0BCCCB8Q35341724-58807717-5D79-4747-B069-D27CAB4CCA7EQ35998932-4E0C2BF5-7562-4023-BDC5-51B1076A53ACQ36348442-E40D1B82-6165-43B1-BAA6-F2FBEEE4916DQ36375290-3A8375B4-9184-4F0D-8B7A-560763CCBEE5Q37084341-DEC25E2D-A5A5-463D-B3C1-44A1DB3920C7Q37372290-48C38D43-9950-4DAE-8EC0-BF7A2F4AAF41Q37567027-90662793-2E95-491D-ADCD-A83A2DA4179EQ41046811-9488C355-43CC-47DF-8398-7ECD065CA3AEQ41387601-1059A73F-0130-430B-98CF-C0D313F73DD0Q42176949-121B6D36-8BE3-49D2-A6B8-7ACF37359437Q47146390-05A97B79-4BF1-4BE4-AD86-49B7EDF07D27Q47148282-6848A733-0DA3-4970-BAFB-70E8C245D28A
P2860
Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Modified low density lipoprote ...... iabetes macrovascular disease.
@ast
Modified low density lipoprote ...... iabetes macrovascular disease.
@en
Modified low density lipoprote ...... iabetes macrovascular disease.
@nl
type
label
Modified low density lipoprote ...... iabetes macrovascular disease.
@ast
Modified low density lipoprote ...... iabetes macrovascular disease.
@en
Modified low density lipoprote ...... iabetes macrovascular disease.
@nl
prefLabel
Modified low density lipoprote ...... iabetes macrovascular disease.
@ast
Modified low density lipoprote ...... iabetes macrovascular disease.
@en
Modified low density lipoprote ...... iabetes macrovascular disease.
@nl
P2093
P2860
P921
P356
P1476
Modified low density lipoprote ...... diabetes macrovascular disease
@en
P2093
Alexander N Orekhov
Dimitry A Chistiakov
Yuri V Bobryshev
P2860
P304
12807-12841
P356
10.3390/IJMS150712807
P407
P5008
P577
2014-07-21T00:00:00Z